inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
Isoniazid (isonicotinic acid hydrazide, INH) is one of the most widely used antituberculosis drugs, yet its precise target of action on Mycobacterium tuberculosis is unknown. A missense mutation within the mycobacterial inhA gene was shown to confer resistance to both INH and ethionamide (ETH) in M. smegmatis and in M. bovis . The wild-type inhA gene also conferred INH and ETH resistance when transferred on a multicopy plasmid vector to M. smegmatis and M. bovis BCG. The InhA protein shows significant sequence conservation with the Escherichia coli enzyme EnvM, and cell-free assays indicate that it may be involved in mycolic acid biosynthesis. These results suggest that InhA is likely a primary target of action for INH and ETH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“inhA was identified as the target of activated INH by an M. smegmatis missense mutation that conferred co-resistance to both INH and Ethionamide (ETH) (129).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [129]
Citations
Cites
Introduction to Protein Structure
Branden, C. I., & Tooze, J. (2012) · Garland Science eBooks · doi:10.1201/9781136969898 · Cited by 2,382
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Self-citationThe Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 939
Tuberculosis in developing countries: burden, intervention and cost.
Murray, C. J. L., Styblo, K., & Rouillon, A. (1990) · PubMed · Cited by 571
[25] Genetic systems for mycobacteria
Jacobs, W. R., Kalpana, G. V., Cirillo, J. D., Pascopella, L., Snapper, S. B., Udani, R. A., Jones, W., Barletta, R. G., & Bloom, B. R. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)04027-l · Cited by 433
Self-citationSnider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Combs, D. L., O'Brien, R. J., & Geiter, L. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-397 · Cited by 315
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Coderre, J. A., Beverley, S. M., Schimke, R. T., & Santi, D. V. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2132 · Cited by 239
Present aspects of bacterial resistance in tuberculosis.
Canetti, G. (1965) · PubMed · doi:10.1164/arrd.1965.92.5.687 · Cited by 211
The ligase chain reaction in a PCR world.
Barany, F. (1991) · Genome Research · doi:10.1101/gr.1.1.5 · Cited by 208
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
BERNSTEIN, J., Lott, W. A., Steinberg, B. A., & Yale, H. L. (1952) · PubMed · doi:10.1164/art.1952.65.4.357 · Cited by 160
Insertional mutagenesis and illegitimate recombination in mycobacteria.
Kalpana, G. V., Bloom, B. R., & Jacobs, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5433 · Cited by 152
Self-citationA rifampicin resistent rna‐polymerase from E. coli altered in the β‐subunit
Rabussay, D., & Zillig, W. (1969) · FEBS Letters · doi:10.1016/0014-5793(69)80305-4 · Cited by 150
The Chemical Approach to the Control of Tuberculosis
FOX, H. H. (1952) · Science · doi:10.1126/science.116.3006.129 · Cited by 134
Quémard, A., Lacave, C. S., & Lanéelle, G. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1035 · Cited by 121
Mechanisms of Resistance to Trimethoprim, the Sulfonamides, and Trimethoprim-Sulfamethoxazole
Then, R. L. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.261 · Cited by 108
American Review of Tuberculosis
Wolepor, B. (1929) · AJN American Journal of Nursing · doi:10.1097/00000446-192905000-00034 · Cited by 104
Middlebrook, G. (1952) · PubMed · Cited by 100
Cohn, M. L., Kovitz, C., ODA, U., & Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.70.4.641 · Cited by 98
envM genes of Salmonella typhimurium and Escherichia coli
Turnowsky, F., Fuchs, K. P., Jeschek, C., & Högenauer, G. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.12.6555-6565.1989 · Cited by 89
Belisle, J. T., Pascopella, L., Inamine, J. M., Brennan, P. J., & Jacobs, W. R. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.21.6991-6997.1991 · Cited by 81
Self-citationA review of the action of isoniazid.
Youatt, J. (1969) · PubMed · doi:10.1164/arrd.1969.99.5.729 · Cited by 80
Effects of Ethionamide and Isoxyl on Mycolic Acid Synthesis in Mycobacterium tuberculosis bcg
Winder, F. G., Collins, P. B., & Whelan, D. (1971) · Journal of General Microbiology · doi:10.1099/00221287-66-3-379 · Cited by 75
Stoeckle, M. Y., Guan, L. L., Riegler, N., Weitzman, I., Kreiswirth, B. N., Kornblum, J. S., Laraque, F., & Riley, L. W. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1063 · Cited by 70
Sequences of the envM gene and of two mutated alleles in Escherichia coli
Bergler, H., Högenauer, G., & Turnowsky, F. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-10-2093 · Cited by 62
Nag, D. K., Huang, H. V., & Berg, D. E. (1988) · Gene · doi:10.1016/0378-1119(88)90487-8 · Cited by 60
In vitro studies on isonicotinic acid hydrazide.
PANSY, F. E., Stander, H. J., & Donovick, R. (1952) · PubMed · Cited by 42
Incidence and Mechanisms of Resistance to Trimethoprim in Clinically Isolated Gram-Negative Bacteria
Grey, D., Hamilton-Miller, J. M. T., & Brumfitt, W. (2009) · Chemotherapy · doi:10.1159/000237834 · Cited by 38
Lacave, C. S., Quémard, A., & Lanéelle, G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90203-a · Cited by 27
Brennan, P. J., Rooney, S. A., & WINDER, F. G. (1970) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02956904 · Cited by 23
Transduction of Isoniazid Susceptibility-Resistance and Streptomycin Resistance in Mycobacteria
Saroja, D., & Gopinathan, K. P. (1973) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.4.6.643 · Cited by 19
Lopez-Marin, L. M., Quémard, A., Lanéelle, G., & Lacave, C. S. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90150-g · Cited by 16
The ethionamide sensitivity of british pre-treatment strains of mycobacterium tuberculosis
Lefford, M. J. (1966) · Tubercle · doi:10.1016/s0041-3879(66)80036-3 · Cited by 16
Lefford, M. J., Mitchison, D. A., & Tall, R. (1966) · Tubercle · doi:10.1016/s0041-3879(66)80054-5 · Cited by 12
Research works printed but not linked: 8
- BEGGS, W.H., AM REV RESPIR DIS 102: 94 (1969).
- GOPINATHAN, K.P., SPECIFICITY OF ISONIAZID ACTION AGAINST MYCOBACTERIA AND A POSSIBLE MECHANISM FOR THE DEVELOPMENT OF DRUG-RESISTANCE, CURRENT SCIENCE 50: 216 (1981).
- GRUMBACH, F, REVUE DE TUBERCULOSE ET DE PNEUMOLOGIE 25: 1365 (1961).
- MIDDLEBROOK, G, AMERICAN REVIEW OF TUBERCULOSIS 65: 765 (1952).
- MURRAY, C. J. L., BULLETIN OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE 65: 6 (1990).
- Murray, C., Disease Control Priorities in Developing Countries: 233 (1993).
- OFFE, H.A., ZEITSCHRIFT FUR NATURFORSCHUNG 76: 462 (1952).
- PANSY, F, INVITRO STUDIES ON ISONICOTINIC ACID HYDRAZIDE, AMERICAN REVIEW OF TUBERCULOSIS 65: 761 (1952).
Cited by
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
“Several different components of FAS II may be targets for the important tuberculosis drug isoniazid, including the enoyl-ACP reductase Inh”
BackgroundPlatforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154
“The fact that M. tuberculosis in a chronically infected mouse model is susceptible to isoniazid (INH) (238), a drug that is effective only against growing M. tuberculosis (308), provides evidence for the latter explanation, i.e., balanced growth and death.”
BackgroundInfluentialMolecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
“coli, an enzyme involved in fatty acid biosynthesis.(96) The mycobacterial”
BackgroundResultWHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Metadata
- Authors
- Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R.
- Affiliations
- Albert Einstein College of Medicine (US)
- Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, NY 10461.
- AgResearch (NZ)
- AgResearch, Wallaceville Animal Research Center, Upper Hutt, New Zealand.
- Venue
- Science
- Published
- 1994-01-14
- Volume
- 263
- Issue
- 5144
- Pages
- 227-230
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2075000963
- Cited by
- 1,389
- References
- 46
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 31 · 2023: 43 · 2022: 49 · 2021: 39 · 2020: 45 · 2019: 52 · 2018: 52 · 2017: 62 · 2016: 45 · 2015: 54 · 2014: 69 · 2013: 39 · 2012: 57
- FWCI
- 46.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01ai030189-03)
- National Institute of Allergy and Infectious Diseases (AI 27160, UO1AI30189)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- inhA gene, isoniazid, ethionamide, Mycobacterium tuberculosis, therapeutic target, drug resistance, missense mutations, mycolic acid biosynthesis, Mycobacterium smegmatis, Mycobacterium bovis BCG, antitubercular agents
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Cloning, Molecular, Drug Resistance, Microbial, Ethionamide, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium, Mycobacterium bovis, Mycobacterium tuberculosis, Mycolic Acids, Oxidoreductases, Open Reading Frames, Sequence Alignment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.